A novel drug called enzalutamide may extend overall survival for men with nonmetastatic, castration-resistant prostate cancer, according to findings from clinical trial published in The New England Journal of Medicine.
A new patient-centered decision support tool aims to help pregnant women decide whether they prefer trial-of-labor or a repeat cesarean delivery after having a prior cesarean.
A protein gives motile cilia part of their structure, according to a recent Northwestern Medicine study.
A drug originally designed as cancer therapy virtually eliminated allergic reactions in moderate cases and significantly lessened the risk of death in severe cases, according to a new study in animal models.
A novel compound using diphtheria toxin to attack a signaling pathway implicated in as many as 50 percent of cancers slowed tumor growth, according to a recent study.
The gene transcription machinery that controls circadian rhythms also regulates insulin release in the pancreas, according to a Northwestern Medicine study.
A protein called mDia2 is vital for proper bone marrow transplantation, according to a new study.
Machine-learning technology could help pathologists more accurately assess how a patient’s immune system is responding to breast cancer, according to a recent series of reports authored in part by Feinberg faculty.
A genetic screen has revealed previously unknown regulators of Foxp3, a transcription factor that, when deactivated, may improve patient response to aggressive cancers.
Northwestern Medicine investigators undertook a massive, new, daily home-monitoring program of patients presumed positive for COVID-19 with the assistance of nurses, nurse practitioners, a large workforce of medical students, physicians’ assistants and daily questionnaires delivered through electronic health records.